[{"from": "human", "value": "Could you provide a description of this molecule? [C][C@@H1][C][/C][=C][/C][=C][/C@@H1][Branch2][#Branch1][C][C@@H1][Branch2][=Branch1][=N][C][C@@H1][Branch2][=Branch1][Branch1][C@@H1][Branch2][Ring1][C][C@H1][Branch1][=N][C@@H1][Branch1][=Branch2][C][C][=Branch1][C][=O][O][Ring1][P][O][O][C][O][C@H1][C@@H1][Branch2][Ring2][=Branch2][C@H1][Branch2][Ring1][S][C@@H1][Branch1][Branch2][C@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][C@H1][C][C@@][Branch1][N][C@H1][Branch1][Branch2][C@@H1][Branch1][Ring2][O][Ring1][=Branch1][C][O][Branch1][C][C][O][N][Branch1][C][C][C][O][C][C][=O][C][O][C@H1][C][C][C@@H1][Branch1][Branch2][C@@H1][Branch1][Ring2][O][Ring1][=Branch1][C][N][Branch1][C][C][C]"}, {"from": "gpt", "value": "The molecule is a primarily bacteriostatic macrolide antimicrobial agent with activity against Gram-positive cocci and rods, Gram-negative cocci and also Legionellae, mycoplasmas, chlamydiae, some types of spirochetes, Toxoplasma gondii and Cryptosporidium. Spiramycin is a 16-membered ring macrolide discovered in 1952 as a product of Streptomyces ambofaciens that has been available in oral formulations since 1955, and parenteral formulations since 1987. Resistant organisms include Enterobacteria, pseudomonads, and moulds."}]